✦ LIBER ✦

3.126 EVALUATION OF DRUGS ACTING ON CB1-A2A RECEPTOR OLIGOMERS IN RAT MODELS OF PARKINSON'S DISEASE

✍ Scribed by N. Simola; G. Costa; C.E. Muller; M.T. Armentero; R. Franco; A. Pinna

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of rimonabant, a selective canna

✍ Sara González; Camila Scorticati; Moisés García-Arencibia; Rosario de Miguel; Jo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 331 KB

Drugs acting on dopamine receptors: Usef

✍ G.U. Corsini; M. Del Zompo; F. Tocco; P. Arca; G.L. Gessa 📂 Article 📅 1980 🏛 Elsevier Science ⚖ 441 KB

Anti-dyskinetic effects of cannabinoids

✍ Maria Grazia Morgese; Tommaso Cassano; Vincenzo Cuomo; Andrea Giuffrida 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 650 KB

1004 SUPPRESSION OF BLADDER OVERACTIVITY

✍ Kitta, Takeya; Nonomura, Katsuya; Yoshimura, Naoki 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 66 KB

A2A/D2 receptor heteromerization in a mo

✍ Ferraro, Luca; Beggiato, Sarah; Tomasini, Maria Cristina; Fuxe, Kjell; Antonelli 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 507 KB

Chronic treatment with CB1 or CB2 cannab

✍ Aso, Ester; Juvés, Salvador; Maldonado, Rafael; Ferrer, Isidre 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 40 KB